VolitionRX (VNRX) Stock Statistics & Valuation Metrics

VolitionRX has a market cap or net worth of $44.29M. The enterprise value is $42.56M.

VolitionRX has 103,022,675 shares outstanding. The number of shares has decreased by -2.65% in one year.

VolitionRX’s return on equity (ROE) is 1.08 and return on invested capital (ROIC) is -899.04%.

The current PE Ratio of VolitionRX is -1.93. VolitionRX’s PEG ratio is -0.14.

In the last 12 months, VolitionRX had revenue of 1.23M and earned -26.97M in profits. Earnings per share was -0.31.

In the last 12 months, operating cash flow was -21.85M and capital expenditures -496.85K, giving a free cash flow of -22.11M billion.

VolitionRX pays an annual dividend of ―, resulting in a dividend yield of ―

VolitionRX upcoming earnings date is Aug 13, 2025, TBA Not Confirmed.

VolitionRX as a current ratio of 0.52, with Debt / Equity ratio of -8.85%

In the past 12 months, VolitionRX has paid 0.00 in taxes.

VolitionRX EV to EBITDA ratio is -2.13, with an EV/FCF ratio of -2.08.

VolitionRX has $2.60M in cash and marketable securities with $1.84M in debt, giving a net cash position of -$763.81K billion.

Gross margin is 31.67%, with operating margin of -2190.90%, and net profit margin of -2186.27%.

The average price target for VolitionRX is $2.50, which is 11.43% higher than the current price. The consensus rating is Moderate Buy